You should have gone to the shareholder meeting and asked Maggs what he thinks about his investment.
I can tell you what he thinks about his investment but its best if you hear it from the horse's mouth.
"Can't get out" ..... I don't believe he wants to get out ..... at least not at this juncture. I'm pretty sure there is some frustration with the process and slowness of progress. But .... as I've said before, should this company prove its model and be commercialized correctly it is positioned to be bought out easily .... or .... it literally could become a cash generating machine with minimal penetration into multiple verticals.
So if they get to commercialization, there will be options for being able to "get out" for everyone.
They've paid the price of proving the algae and its derivatives out without a full science staff. They've worked with experts in their field. Some bumps and missteps here and there. Not entirely unexpected. But they now have companies who would be their commercial partners considering licensing based on the accumulated data. Many possible vertical options. Its been a long time but they are getting close.
One thing they still haven't done is change Dahl's contract where it calls for 2% of revenue as I recall after some conditions are met. Needs to be eliminated PRONTO. And especially so if they are nearing any sniff of license fees and commercial contracts.
The stock is lingering near highs for the year. Consolidating a triple in price. Good enough for now. No one seems in a hurry to knock out the wall at .12. We'll see how 2017 plays.
Merry Christmas .... and yes ..... maybe one day. Time will tell.
Amigo Mike
News 
Market Data 
Discover 
